Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated:  9/28/2016
GSK Investigational Site
mi
from
Providence, RI
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated: 9/28/2016
GSK Investigational Site
mi
from
Providence, RI
Click here to add this to my saved trials
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated:  9/28/2016
GSK Investigational Site
mi
from
Austin, TX
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated: 9/28/2016
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated:  9/28/2016
GSK Investigational Site
mi
from
South Ogden, UT
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated: 9/28/2016
GSK Investigational Site
mi
from
South Ogden, UT
Click here to add this to my saved trials
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated:  9/28/2016
GSK Investigational Site
mi
from
Bennington, VT
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated: 9/28/2016
GSK Investigational Site
mi
from
Bennington, VT
Click here to add this to my saved trials
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated:  9/28/2016
GSK Investigational Site
mi
from
Milwaukee, WI
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated: 9/28/2016
GSK Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated:  9/28/2016
GSK Investigational Site
mi
from
Ciudad Autonoma de Buenos Aires,
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).
Status: Enrolling
Updated: 9/28/2016
GSK Investigational Site
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Litchfield Park, AZ
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Litchfield Park, AZ
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Scottsdale, AZ
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Sun City, AZ
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Sun City, AZ
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Tucson, AZ
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Belmont, MA
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Belmont, MA
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Ann Arbor, MI
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Durham, NC
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated:  11/15/2016
GSK Investigational Site
mi
from
Montreal,
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)
Status: Enrolling
Updated: 11/15/2016
GSK Investigational Site
mi
from
Montreal,
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Anaheim, CA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Fullerton, CA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Fullerton, CA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Lomita, CA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
San Diego, CA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
San Diego, CA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
San Francisco, CA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Santa Monica, CA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
New Haven, CT
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Norwalk, CT
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Norwalk, CT
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Boca Raton, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Brooksville, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Brooksville, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Delray Beach, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Delray Beach, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Miami, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Miami Springs, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Miami Springs, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Orange City, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Orange City, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Orlando, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
St Petersburg, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
St Petersburg, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Tampa, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Decatur, GA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Decatur, GA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Elk Grove Village, IL
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
New Orleans, LA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Shreveport, LA
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Traverse City, MI
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Traverse City, MI
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Hattiesburg, MS
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Creve Coeur, MO
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Eatontown, NJ
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Eatontown, NJ
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Albuquerque, NM
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
New York, NY
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Staten Island, NY
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Raleigh, NC
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated:  11/17/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of RO4602522 Added To Background Alzheimer's Disease Therapy In Patients With Moderate Severity Alzheimer's Disease
Status: Enrolling
Updated: 11/17/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials